ReNerve
Melbourne, AU · 12 employees on LinkedIn · 1 known investors
ReNerve develops nerve repair products, including cuffs, grafts, and bionic nerve structures, to treat transected nerves and improve patient outcomes. The company operates research laboratories in Melbourne, Australia, and collaborates with researchers at the CSIRO / Monash University biomaterials precinct.
Founders & leadership
DR
David RhodesDirector & CSO
AA
Alex AdamidesChief Medical Officer
Board
JC
Julian ChickBoard director
MM
Maja McGuireIndependent Chair
PS
Paul SavageIndependent Non-executive Director
Investors · 1
In the news
ReNerve Limited Schedules Investor Webinar for 19 August 2026 to Discuss Quarterly Reportkalkinemedia.com · Aug 2026
ReNerve Reports Record $211K Quarterly Sales Amid Asia-Pacific Market Expansion and $5M Funding Boostkalkinemedia.com · Jul 2026ReNerve Limited Raises Capital Through 1.6 Million Unlisted Convertible Notes to Enhance Financial Stabilitykalkinemedia.com · Jul 2026
ReNerve Funding Boost Signals Next Phase of Global Expansionkalkinemedia.com · Jul 2026
ReNerve secures up to A$5 million facility to drive commercial growth | ASX:RNV, OTC:RNVEFproactiveinvestors.com · Jul 2026Frequently asked questions
- What does ReNerve do?
- ReNerve develops nerve repair products, including cuffs, grafts, and bionic nerve structures, to treat transected nerves and improve patient outcomes. The company operates research laboratories in Melbourne, Australia, and collaborates with researchers at the CSIRO / Monash University biomaterials precinct.
- Who are ReNerve's investors?
- ReNerve's investors include Starfish Ventures.
- Where is ReNerve headquartered?
- ReNerve is headquartered in Melbourne, AU.